Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2006
12/21/2006US20060286608 Method for screening transglutaminase 2 inhibitor or activator
12/21/2006US20060286606 Clandestine Laboratory (Clan-Lab) Home Test Kit system, protocol, method and apparatus
12/21/2006US20060286605 Calcium biosensor polypeptides and methods of use
12/21/2006US20060286604 Lectin binding to choroidal neovascularization
12/21/2006US20060286603 Combinatorial libraries of monomer domains
12/21/2006US20060286602 Method and markers for the diagnosis of renal diseases
12/21/2006US20060286601 Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
12/21/2006US20060286600 High throughput one-hybrid system
12/21/2006US20060286599 Open channel solid phase extraction systems and methods
12/21/2006US20060286597 Aortic carboxypeptidase-like polypeptide
12/21/2006US20060286595 Independent of the patient's human papilloma virus (HPV) infection status by detecting biomarker(s) selectively overexpressed in high-grade cervical disease; kits
12/21/2006US20060286593 Transforming Growth Factor Alpha HI
12/21/2006US20060286584 Compositions and methods for the regulation of cell proliferation and apoptosis
12/21/2006US20060286581 Heteroconfigurational Polynucleotides and Methods of Use
12/21/2006US20060286567 Salicylamide-lanthanide complexes for use as luminescent markers
12/21/2006US20060286564 Modified Pol III replicases and uses thereof
12/21/2006US20060286563 Surface modified to prevent non-specific binding; magnetic field draws material to sensor to produce acoustic effect which is converted to amount of substance in sample
12/21/2006US20060286556 Autoimmune encephalomyelitis; multiple sclerosis; antagonize or inhibit CXCL13
12/21/2006US20060286555 Microarray support for bioprobe synthesis
12/21/2006US20060286550 Substrates for isolating, reacting and microscopically analyzing materials
12/21/2006US20060286548 Method of making recombinant human antibodies for use in biosensor technology
12/21/2006US20060286547 Time-of-addition assay for identifying anti-viral compounds
12/21/2006US20060286546 Using gold-particle labelled reagents and an antibody conjugate to bind to a probe; cost efficiency, environmentally friendly
12/21/2006US20060286423 Gas Composition monitoring arrangement
12/21/2006US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006US20060286122 Modulation of angiogenesis by Bartonella henselae
12/21/2006US20060286119 Compositions and methods for treatment of chronic and infectious diseases
12/21/2006US20060286116 Methods and compositions for treating B cell cancer
12/21/2006US20060286112 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
12/21/2006US20060286107 Parathyroid hormone antibodies and related methods
12/21/2006US20060286106 determining total protein bound or total free levels or both of one or more myeloperoxidase (MPO)-generated amino acids in a bodily sample of blood, serum, plasma, or urine from the patient
12/21/2006US20060286104 Superagonistic anti-CD28 antibodies
12/21/2006US20060286091 RelA-ASSOCIATED INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
12/21/2006US20060286090 Mediators of epithelial adhesion and their role in cancer and skin disorders
12/21/2006US20060286085 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
12/21/2006US20060286047 Methods for determining the sequence of a peptide motif having affinity for a substrate
12/21/2006US20060286035 Methods and compositions for modulating the interaction between adiponectin and its receptor
12/21/2006US20060286034 Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders
12/21/2006US20060286031 Modulators of tissue regeneration
12/21/2006US20060285104 Molecular imager
12/21/2006US20060284073 Method and apparatus for analysing combustion products
12/21/2006US20060283706 Biosensor arrangement and method for producing it
12/21/2006US20060283269 Fluid sampling components
12/21/2006US20060283244 Measuring device for determining the characteristics and the level of a brake fluid in a motor vehicle
12/21/2006US20060283238 Submersible probe
12/21/2006DE202006014425U1 Automatic tablet test canister has three tubes with discs holding ring magnets placed on tablets and magnetic sensors under sieve
12/21/2006DE112005000248T5 Verfahren und Vorrichtung zur thermischen Isolation eines Gassensors Method and apparatus for thermal insulation of a gas sensor
12/21/2006DE102006026894A1 Nichtoptisches Lesen von Testzonen Non-optical reading of test zones
12/21/2006DE102005042262B3 Histological tissue sample cutting device comprises white plastic working board having working face, high-grade steel rectangular trim-cutting units for inserting and cutting the samples by knife, and plastic trim adapter
12/21/2006DE102005028018A1 Verfahren zur Standardisierung von Gerinnungstesten Method for the standardization of coagulation tests
12/21/2006DE102005026839A1 Verfahren und Vorrichtung zur quantitativen Bestimmung von Analyten in flüssigen Proben Method and apparatus for the quantitative determination of analytes in liquid samples
12/21/2006DE10113042B4 HIV-Inhibitor Screening-System HIV inhibitor screening system
12/21/2006CA2640335A1 Rapid saccharide biomarker assay
12/21/2006CA2614299A1 Method of assaying blood component by using whole blood and measurement kit
12/21/2006CA2612281A1 Method for diagnosing alzheimer's disease
12/21/2006CA2611951A1 Method of processing and/or genome mapping of ditag sequences
12/21/2006CA2611828A1 Method for screening anticancer substances, set or kit for implementing said method
12/21/2006CA2611365A1 Process for the identification of novel enzyme interacting compounds
12/21/2006CA2611048A1 Psp94 diagnostic reagents and assays
12/21/2006CA2610910A1 Methods and compositions for the diagnosis of venous thromboembolic disease
12/21/2006CA2610833A1 Methods for diagnosing and treating cerebrovascular events based on nr2 peptides
12/20/2006EP1734369A1 Procedure for the standardisation of coagulation tests
12/20/2006EP1734368A2 Annexins and autoantibodies used as markers for cancer
12/20/2006EP1734367A1 Process for the identification of novel enzyme interacting compounds
12/20/2006EP1734366A2 New method for the detection of acid-resistant micro-organisms in stool
12/20/2006EP1734365A1 Body fluid analysis device with test band having test fields
12/20/2006EP1734364A2 Method and device for accelerated determination of the oxidation of fuels or mineral oil products and a computer program for controlling such a device and a corresponding computer readable storage medium
12/20/2006EP1734362A2 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices
12/20/2006EP1734361A1 Method and device for measuring grammage (basis weight, mass per unit area) and moisture of a sheet, for example of paper, using a dielectric resonator
12/20/2006EP1734359A1 RAMAN spectroscopic analysis method and system therefor
12/20/2006EP1734347A2 Apparatus for metering consumption and carbon dioxide content of natural gas
12/20/2006EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications
12/20/2006EP1734132A1 Method of determining carbonic anhydrase i activity
12/20/2006EP1734124A1 Prostate specific antigen peptides and uses thereof
12/20/2006EP1734120A2 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
12/20/2006EP1734118A1 Identification of JAK/STAT pathway modulating genes by genome wide RNAi screening
12/20/2006EP1734054A2 Anti-human thymidylate synthase monoclonal antibody and hybridoma capable of producing the same
12/20/2006EP1734051A2 Composition and methods for the diagnosis of tumours
12/20/2006EP1734050A2 Immunization of dairy cattle with GapC protein against streptococcus infection
12/20/2006EP1734049A1 Tumour-associated peptides that bind to MHC-molecules
12/20/2006EP1734048A1 Tumor-associated peptides that bind to MHC-molecules
12/20/2006EP1733792A1 Diagnostic devices and apparatus for the controlled movement of reagents without membranes
12/20/2006EP1733743A1 Preventives/remedies for cancer
12/20/2006EP1733739A1 sFRP EXPRESSION POTENTIATING AGENT
12/20/2006EP1733738A1 Method of preventing ultraviolet ray-induced apoptosis
12/20/2006EP1733437A1 Immunoassay reagents and methods of use thereof
12/20/2006EP1733238A2 Transmissible spongiform encephalopathy test reagents and methods using them
12/20/2006EP1733237A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara)
12/20/2006EP1733236A1 Method to predict risk of bph progression
12/20/2006EP1733235A1 Improved lateral flow binding assay
12/20/2006EP1733234A2 Methods of determining allergen response using microarray imminoassay techinques
12/20/2006EP1733233A2 Lateral flow format, materials and mehtods
12/20/2006EP1733232A1 Hybrid phase lateral flow assay
12/20/2006EP1733231A2 Peptides and peptidomimetics binding to cd23
12/20/2006EP1733230A1 Assays for amphetamine and methamphetamine using stereospecific reagents
12/20/2006EP1733229A1 Patterning method for biosensor applications and devices comprising such patterns
12/20/2006EP1733228A1 Multiwell plate assembly for use in high throughput assays
12/20/2006EP1733227A1 Devices and methods for measuring clinically relevant analytes in fluids
12/20/2006EP1733226A2 Disposable chamber for analyzing biologic fluids
12/20/2006EP1733225A2 Multiple sorter monitor and control subsystem for flow cytometer